A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter

Human Gene Therapy

Volumn 11, Issue 10, 2000, Pages 1397-1406

  Koga, Shoji ^a   Hirohata, Satoshi ^a   Kondo, Yasuko ^a,b   Komata, Tadashi ^a,b   Takakura, Masahiro ^c   Inoue, Masaki ^c   Kyo, Saturo ^c   Kondo, Seiji ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; TELOMERASE; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CATALYSIS; CELL DEATH; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FIBROBLAST; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; TARGET CELL; TREATMENT INDICATION; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CATALYTIC DOMAIN; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IN SITU NICK-END LABELING; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; PROMOTER REGIONS (GENETICS); RNA; RNA, MESSENGER; SIMIAN VIRUS 40; TELOMERASE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034235413     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050057477     Document Type: Article

References (58)

1. AHMAD, M., SRINIVASULA, S.M., WANG, L., TALANIAN, R.V., LITWACK, G., FERNANDES-ALNEMRI, T., and ALNEMRI, E.S. (1997). CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57, 615-619.
2. ALNEMRI, E.S., LIVINGSTON, D.J., NICHOLSON, D.W., SALVESEN, G., THORNBERRY, N.A., WONG, W.W., and YUAN, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
3. BACCHETTI, S., and COUNTER, C.M. (1995). Telomeres and telomerase in human cancer. Int. J. Oncol. 7, 423-432.
4. BAKER, S.J., MARKOWITZ, S., FEARON, E.R., WILLSON, J.K., and VOGELSTEIN, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
5. BLACKBURN, E.H. (1991). Structure and function of telomeres. Nature (London) 350, 569-573.
6. BOLD, R.J., TERMUHLEN, P.M. and MCCONKEY, D.J. (1997). Apoptosis, cancer and cancer therapy. Surg. Oncol. 6, 133-142.
7. CHEN, X., KO, L.J., JAYARAMAN, L., and PRIVES, C. (1996). P53 levels, functional domains and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-2451.
8. CHEN, Y.M., CHEN, P.L., ARNAIZ, N., GOODRICH, D., and LEE, W.H. (1991). Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene 6, 1799-1805.
9. DUAN, H., and DIXIT, V.M. (1997). RAIDD is a new "death" adaptor molecule. Nature (London) 385, 86-89.
10. EASTHAM, J.A., HALL, S.J., SEHGAL, I., WANG, J., TIMME, T.L., YANG, G., CONNELL-CROWLEY, L., ELLEDGE, S.J., ZHANG, W.W., and HARPER, J.W. (1995). In vivo gene therapy with p53 or p21 for prostate cancer. Cancer Res. 55, 5151-5155.
11. ELLIS, R.E., YUAN, Y., and HORVITZ, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell. Biol. 7, 663-698.
12. FAVROT, M., COLL, J.L., LOUIS, N., and NEGOESCU, A. (1998). Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Ther. 5, 728-739.
13. FENG, J., FUNK, W.D., WANG, S.-S., WEINRICH, S.L., AVILION, A.A., CHIU, C.-P., ADAMS, R.R., CHANG, E., ALLSOPP, R.C., YU, J., LE, S., WEST, M.D., HARLEY, C.B., ANDREWS, W.H., GREIDER, C.W., and VILLEPONTEAU, B. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
14. FERNANDES-ALNEMRI, T., LITWACK, G., and ALNEMRI, E.S. (1994). CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1 β-converting enzyme. J. Biol. Chem. 269, 30761-30764.
15. FERNANDES-ALNEMRI, T., LITWACK, G., and ALNEMRI, E.S. (1995a). Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55, 2737-2742.
16. FERNANDES-ALNEMRI, T., TAKAHASHI, A., ARMSTRONG, R., KREBS, J., FRITZ, L., TOMASELLI, K.J., WANG, L., YU, Z., CROCE, C.M., EARNSHOW, W.C., and ALNEMRI, E.S. (1995b). Mch3, a novel human apoptotic cystein protease highly related to CPP32. Cancer Res. 55, 6045-6052.
17. GAGLIARDINI, V., FERNANDEZ, P.A., LEE, R.K.K., DREXLER, H.C.A., ROTELLO, R.J., FISHMAN, M.C., and YUAN, J. (1994). Prevention of vertebrate neuronal death by the crmA gene. Science 263, 826-828.
18. HARRINGTON, L., MCPHAIL, T., MAR, V., ZHOU, W., OULTON, R., BASS, M.B., ARRUDA, I., and ROBINSON, M.O. (1997). A mammalian telomerase-associated protein. Science 275, 973-977.
19. HARRIS, C.C. (1996). Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88, 1442-1455.
20. HORIKAWA, I., CABLE, P.L., AFSHARI, C., and BARRETT, J.C. (1999). Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59, 826-830.
21. HUMKE, E.W., NI, J., and DIXIT, V.M. (1998). ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 273, 15702-15707.
22. KAUFMAN, S.H. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptotecin, and other cytotoxic anti-cancer drugs; a cautionary note. Cancer Res. 49, 5870-5878.
23. KIM, N.W. (1997). Clinical implications of telomerase in cancer. Eur. J. Cancer, 33, 781-786.
24. KIMURA, M., TAGAWA, M., TAKENAGA, K., YAMAGUCHI, T., SAISHO, H., NAKAGAWARA, A., and SAKIYAMA, S. (1997). Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene. Anticancer Res. 17, 879-883.
25. KONDO, S., BARNA, B.P., MORIMURA, T., TAKEUCHI, J., YUAN, J., AKBASAK, A., and BARNETT, G.H. (1995). Interleukin-1 β-converting enzyme (ICE) mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res. 55, 6166-6171.
26. KONDO, S., BARNA, B.P., KONDO, Y., TANAKA, Y., CASEY, G., LIU, J., MORIMURA, T., KAAKAJI, R., PETERSON, J.W., WERBEL, B., and BARNETT, G.H. (1996). WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13, 1279-1285.
27. KONDO, S., TANAKA, Y., KONDO, Y., ISHIZAKA, Y., HITOMI, M., HAQQI, T., LIU, J., BARNETT, G.H., ALNEMRI, E.S., and BARNA, B.P. (1998a). Retroviral transfer of CPP32β gene into malignant gliomas in vitro and in vivo. Cancer Res. 58, 962-967.
28. KONDO, S., ISHIZAKA, Y., OKADA, T., KONDO, Y., HITOMI, M., TANAKA, Y., HAQQI, T., BARNETT, G.H., and BARNA, B.P. (1998b). FADD gene therapy for malignant gliomas in vitro and in vivo. Hum. Gene Ther. 9, 1599-1608.
29. KONDO, S., KONDO, Y., LI, G., SILVERMAN, R.H., and COWELL, J.K. (1998c). Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16, 3323-3330.
30. LEVINE, A.J. (1997). P53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
31. LIU, T.J., EL-NAGGAR, A.K., MCDONNELL, T.J., STECK, K.D., WANG, M., TAYLOR, D.L., and CLAYMAN, G.L. (1995). Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55, 3117-3122.
32. MACFARLANE, M., AHMAD, M., SRINIVASULA, S.M., FERNANDES-ALNEMRI, T., COHEN, G.M., and ALNEMRI, E.S. (1997). Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272, 25417-25420.
33. MARCELLI, M., CUNNINGHAM, G.R., WALKUP, M., HE, Z., STURGIS, L., KAGAN, C., MANNUCCI, R., NICOLETTI, I., TENG, B., and DENNER, L. (1999). Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: Overexpression of caspase-7 as a new gene therapy strategy for prostate cancer. Cancer Res. 59, 382-390.
34. MCDONNELL, T.J., MEYN, R.E., and ROBERTSON, L.E. (1995). Implications of apoptotic cell death regulation in cancer therapy. Semin. Cancer Biol. 6, 53-60.
35. MERCER, W.E., SHIELDS, M.T., AMIN, M., SAUVE, G.J., APPELLA, E., ROMAND, J.W., and ULLRICH, S.J. (1990). Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. U.S.A. 87, 6166-6170.
36. MEYERSON, M., COUNTER, C.M., EATON, E.N., ELLISEN, L.W., STEINER, P., CADDLE, S.D., ZIAUGRA, L., BEIJERSBERGEN, R.L., DAVIDPOFF, M.L., LIU, W., BACCHETTI, S., HABER, D.A., and WEINBERG, R.A. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
37. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E.A., and YUAN, J. (1993). Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
38. MUZIO, M., CHINNAIYAN, A.M., KISCHKEL, F.C., O'ROURKE, K., SHEVCHENKO, A., NI, J., SCAFFIDI, C., BRETZ, J.D., ZHANG, M., GENTZ, R., MANN, M., KRAMMER, P.H., PETER, M.E., and DIXIT, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
39. NAGATA, S. (1997). Apoptosis by death factor. Cell 88, 355-365. [Review]
40. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER J., HARLEY, C.B., and CECH, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
41. NAKAYAMA, J., SAITO, M., NAKAMURA, H., MATSUURA, A., and ISHIKAWA, F. (1997). TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88, 875-884.
42. NAKAYAMA, J., TAHARA, H., TAHARA, E., SAITO, M., ITO, K., NAKAMURA, H., NAKANISHI, T., IDE, T., and ISHIKAWA, F. (1998). Telomerase activation by hTR in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18, 65-68.
43. ROTH, J.A. (1996). Clinical protocol: Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wild-type (normal) p53. Hum. Gene Ther. 7, 861-874.
44. ROTH, J.A., NGUYEN, D., LAWRENCE, D.D., KEMP, B.L., CARRASCO, C.H., PERSON, D.Z., HONG, W.K., KOMAKI, R., LEE, J.J., NESBITT, J.C., PISTERS, K.M., PUTNAM, J.B., SCHEA, R., SHIN, D.M., WALSH, G.L., DOLORMENTE, M.M., HAN, C.I., MARTIN, F.D., YEN, N., XU, K., STEPHENS, L.C., MCDONNELL, T.J., MUKHOPADHYAY, T., and CAI, D. (1996). Retrovirus mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 2, 985-991.
45. SALA, A., CASELLA, I., GRASSO, L., BELLON, T., REED, J.C., MIYASHITA, T., and PESCHLE, C. (1996). Apoptotic response to oncogenic stimuli: Co-operative and antagonistic interactions between c myb and the growth suppressor p53. Cancer Res. 56, 1991-1996.
46. SHAY, J.W., and WRIGHT, W.E. (1996). Telomerase activity in human cancer. Curr. Opin. Oncol. 8, 66-71.
47. TAKAKURA, M., KYO, S., KANAYA, T., HIRANO, H., TAKEDA, J., YUTSUDO, M., and INOUE, M. (1999). Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59, 551-557.
48. THOMPSON, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
49. THORNBERRY, N.A., RANO, T.A., PETERSON, E.P., RASPER, D.M., TIMKEY, T., GARCIA-CALVO, M., HOUTZAGER, V.M., NORDSTROM, P.A., ROYS, S., VAILLANCOURT, J.P., CHAPMAN, K.T., and NICHOLSON, D.W. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911.
50. WALKER, N.P.C., TALANIAN, R.V., BRADY, K.D., DANG, L.C., BUMP, N.J., FERENZ, C.R., FRANKLIN, S., GHAYUR, T., HACKETT, M.C., HAMMILL, L.D., HERZOG, L., HUGUNIN, M., HOUY, W., MANKOVICH, J.A., MCGUINESS, L., ORLEWICZ, E., PASKIND, M., PRATT, C.A., REIS, P., SUMMANI, A., TERRANOVA, M., WELCH, J.P., XIONG, L., MOLLER, A., TRACEY, D.E., KAMEN, R., and WONG, W.M. (1994). Crystal structure of the cysteine protease interleukin-1 β-converting enzyme: a (p20/p10)2 homodimer. Cell 78, 343-352.
51. WANG, L., MIURA, M., BERGERON, L., ZHU, H., and YUAN, J. (1994). Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750.
52. WANG, X.W., VERMEULEN, W., COURSEN, J.D., GIBSON, M., LUPOLD, S.E., FORRESTER, K., XU, G., ELMORE, L., YEH, H., HOEIJMAKERS, J.H., and HARRIS, C.C. (1996). The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10, 1219-1232.
53. WEINRICH, S.L., PRUZAN, R., MA, L., OUELLETTE, M., TESMER, V.M., HOLT, S.E., BODNAR, A.G., LICHTSTEINER, S., KIM, N.W., TRAGER, J.B., TAYLOR, R.D., CARLOS, R., ANDREWS, W.H., WRIGHT, W.E., SHAY, J.W., HARLEY, C.B., and MRIN, G.B. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTR. Nature Genet 17, 498-502.
54. WILSON, K.P., BLACK, J.A.F., THOMSON, J.A., KIM, E.E., GRIFFITH, J.P., NAVIA, M.A., MURCKO, M.A., CHAMBERS, S.P., ALDAPE, R.A., RAYBUCK, S.A., and LIVINGSTON, D.J. (1994). Structure and mechanism of interleukin-1 β converting enzyme. Nature (London) 370, 270-275.
55. WYLLIE, A.H., KERR, J.F.R., and CURRIE, A.R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-305.
56. WYLLIE, A.H., MORRIS, R.G., SMITH, A.L., and DUNLOP, D. (1984). Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142, 67-77.
57. YU, J., SENA-ESTEVES, M., PAULUS, W., BREAKFIELD, X., and REEVES, S. (1996). Retrovial delivery and tetracycline-dependent expression of IL-1 β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res. 56, 5423-5427.
58. YUAN, J., SHAHAM, S., LEDOUX, S., ELLIS, H.M., and HORVITZ, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzymes. Cell 75, 641-652.